Cerenome, Inc. (CNSY) vs Vyome Holdings, Inc. (HIND)

Cerenome, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Cerenome, Inc. and Vyome Holdings, Inc. are of similar size ($14.5M and $14.3M). Cerenome, Inc. has negative trailing earnings, so its P/E is not meaningful; Vyome Holdings, Inc. trades at 0.0×. Vyome Holdings, Inc. grew revenue faster over the last twelve months: 103.8% against −21.0%. Cerenome, Inc. has the higher net margin (−526.5% vs −8,711.7%) and the lower return on invested capital (−532.8% vs 0.00%). Across the 17 metrics below, Vyome Holdings, Inc. leads on 10 and Cerenome, Inc. on 7.

Valuation

Metric CNSY HIND Biotechnology median
P/E n/m 0.00 7.88
P/S 3.27 110.31 11.47
P/B 2.51 1.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.89 78.55 10.73
Earnings yield (168.84%) 74,921.03% (28.84%)
Free cash flow yield (175.55%) (38.96%) (23.03%)

Profitability

Metric CNSY HIND Biotechnology median
Gross margin 100.00% 52.77% 65.16%
Operating margin (628.12%) (9,184.82%) 0.00%
Net margin (526.48%) (8,711.71%) 0.00%
Free cash flow margin (560.29%) (4,298.00%) 0.00%
Return on equity (520.84%) (172.10%) (57.72%)
Return on assets (181.53%) (124.23%) (49.22%)
Return on invested capital (532.77%) 0.00% 0.00%

Growth

Metric CNSY HIND Biotechnology median
Revenue growth (TTM) (20.95%) 103.81% 5.64%
EPS growth (last fiscal year) 82.79% 99.92% —
Revenue growth, 5-year CAGR (5.72%) (50.98%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSY HIND Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.37 4.37 4.73
Net debt to EBITDA 0.83 0.48 0.96

Dividend

Metric CNSY HIND Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CNSY HIND Biotechnology median
Market cap 14.26m 14.46m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack